Plans 2026 expansion into India
Owlet, the pioneer of smart infant monitoring, announced that the Central Drugs Standard Control Organization (CDSCO) approved Dream Sock for distribution. This marks a significant milestone for the company as it now prepares to launch its integrated monitoring devices, including Dream Sock, Dream Sight, and Dream Duo, across India in early 2026.
With approval from the CDSCO, India's national regulatory body for cosmetics, pharmaceuticals, and medical devices, Owlet becomes one of the few infant health technology companies to meet the region’s stringent medical device requirements, further validating its commitment to clinical rigor and innovation. As smartphone penetration exceeds 80 per cent in urban centers, India’s connected-home environment provides a strong foundation for the adoption of Owlet’s technology.
“India’s rapidly evolving digital health ecosystem aligns perfectly with our mission to make infant care smarter and more accessible for every family,” said Jonathan Harris, Owlet’s President and CEO. “With more than 23 million babies expected to be born in 2025, the highest of any country in the world, India represents a vital opportunity to support new parents during this most important journey. The country is a strategic growth market, where the convergence of digital adoption, healthcare modernisation, and an expanding urban middle class is driving demand for smart, connected health solutions.”
Owlet’s technology supports India’s broader healthcare priorities of improving infant health outcomes and empowering parents with early detection tools. The company’s suite of award-winning products, expected to be available in India in early 2026, includes:
- Dream Sock, a wearable smart baby monitor that is designed for healthy infants between 0-18 months or 2.5-13.6 kg, tracks key vitals in real-time, such as oxygen level and pulse rate, along with sleep trends, providing clinically validated insights.
- Dream Sight, Owlet’s latest intelligent audio and video camera, which offers secure, high-definition monitoring for around-the-clock visibility while detecting motion, sound, and crying.
- Dream Duo, theultimate all-in-one monitoring system, combines Dream Sock and Dream Sight for real-time vital alerts and a complete view of Baby’s wellness and sleep.
- Dream App, a simple, convenient App where families can view live health readings in real-time. Both the Dream App and the included Base Station provide notifications if measurements fall outside preset ranges.
Trusted by over 2 million families across more than 30 countries, the launch of Owlet products in India will bring clinical-grade insights to families seeking the best in infant care. The company’s suite of products is expected to be available for purchase across India early next year, at retail and select baby specialty stores.
